CancerIQ Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 39

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 24

CancerIQ General Information

Description

Developer of a precision health technology designed for doctors to identify and manage patients at high risk for cancer. The company's platform offers predictive analytics and screening tools to identify at-risk patients, clinical guidance with proven outcomes, a digital genetic test ordering platform, and patient management and education tools, enabling clinicians to save time, reduce the cost of care, and improve outcomes by detecting cancer at an early stage.

Contact Information

Website
www.canceriq.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • The Wrigley Building, 400 Michigan Avenue
  • Suite S1000
  • Chicago, IL 60611
  • United States
+1 (312)
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Services
Vertical(s)
Big Data, HealthTech, Life Sciences, Oncology
Corporate Office
  • The Wrigley Building, 400 Michigan Avenue
  • Suite S1000
  • Chicago, IL 60611
  • United States
+1 (312)

CancerIQ Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CancerIQ Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC 21-Aug-2024 Completed Generating Revenue
10. Later Stage VC 10-Nov-2023 Completed Generating Revenue
9. Later Stage VC (Series B) 03-Mar-2022 Completed Generating Revenue
8. Later Stage VC 23-Mar-2021 Completed Generating Revenue
7. Debt - PPP 29-Apr-2020 Completed Generating Revenue
6. Later Stage VC (Series A2) 23-Apr-2020 Completed Generating Revenue
5. Later Stage VC (Series A) 19-Nov-2018 Completed Startup
4. Seed Round 12-Aug-2016 Completed Startup
3. Accelerator/Incubator 28-Oct-2014 $100K Completed Startup
2. Accelerator/Incubator 09-Apr-2014 $100K Completed Startup
To view CancerIQ’s complete valuation and funding history, request access »

CancerIQ Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B2
Series B
Series A2
Series A 2,907,298 $0.000100 $1.23 $1.23 1x $1.23 8.12%
Seed 4,003,578 $0.000100 $0.66 $0.66 1x $0.66 11.18%
To view CancerIQ’s complete cap table history, request access »

CancerIQ Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a precision health technology designed for doctors to identify and manage patients at high risk for cancer.
Decision/Risk Analysis
Chicago, IL
39 As of 2024

Lexington, KY
 

Pittsburgh, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CancerIQ Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Thynk Health Venture Capital-Backed Lexington, KY
Ariel(Decision/Risk Analysis) Venture Capital-Backed Pittsburgh, PA
You’re viewing 2 of 2 competitors. Get the full list »

CancerIQ Executive Team (10)

Name Title Board Seat
Olufeyikemi Ayodele Co-Founder, Chief Executive Officer & Board Member
Ben Bowman Chief Financial Officer
Laku Adedoyin Chief Technology Officer
Olufunmilayo Olopade MD Co-Founder, Chief Scientific Officer & Board Member
Haibo Lu Co-Founder, Chief Product Officer, Chief Data Officer & Board Member
You’re viewing 5 of 10 executive team members. Get the full list »

CancerIQ Board Members (9)

Name Representing Role Since
Andrea Metkus Self Board Member
Carladenise Edwards Ph.D Self Board Member
Joel Krikston Merck Global Health Innovation Fund Board Member
Mark Bakken HealthX Ventures Board Member
Olufeyikemi Ayodele CancerIQ Co-Founder, Chief Executive Officer & Board Member
You’re viewing 5 of 9 board members. Get the full list »

CancerIQ Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CancerIQ Investors (24)

Investor Name Investor Type Holding Investor Since Participating Rounds
Decathlon Capital Partners Lender/Debt Provider Minority
Cleveland Avenue Venture Capital Minority
Amgen Ventures Corporate Venture Capital Minority
HealthX Ventures Venture Capital Minority
McKesson Ventures Corporate Venture Capital Minority
You’re viewing 5 of 24 investors. Get the full list »

Ready to get started?

Request a free trial

CancerIQ FAQs

  • When was CancerIQ founded?

    CancerIQ was founded in 2013.

  • Who is the founder of CancerIQ?

    Olufeyikemi Ayodele, Olufunmilayo Olopade MD, Haibo Lu, and Moe Alkhafaji Ph.D are the founders of CancerIQ.

  • Who is the CEO of CancerIQ?

    Olufeyikemi Ayodele is the CEO of CancerIQ.

  • Where is CancerIQ headquartered?

    CancerIQ is headquartered in Chicago, IL.

  • What is the size of CancerIQ?

    CancerIQ has 39 total employees.

  • What industry is CancerIQ in?

    CancerIQ’s primary industry is Decision/Risk Analysis.

  • Is CancerIQ a private or public company?

    CancerIQ is a Private company.

  • What is CancerIQ’s current revenue?

    The current revenue for CancerIQ is .

  • How much funding has CancerIQ raised over time?

    CancerIQ has raised $30.8M.

  • Who are CancerIQ’s investors?

    Decathlon Capital Partners, Cleveland Avenue, Amgen Ventures, HealthX Ventures, and McKesson Ventures are 5 of 24 investors who have invested in CancerIQ.

  • Who are CancerIQ’s competitors?

    Thynk Health and Ariel(Decision/Risk Analysis) are competitors of CancerIQ.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »